Nasdaq TradeTalks: Pharma’s Untapped Profit Source
HealthPrize CEO Tom Kottler recently spoke with Jill Malandrino, host of Nasdaq’s Trade Talks, about why pharma should look to medication adherence as its new profit source. Watch the video from Nasdaq TV below:
Cost has been one of pharma’s key adherence tactics. But what would happen if we gave away medications for free?
Learn how HealthPrize’s client services team partners with brand marketers to launch digital adherence programs that deliver measurable results.